Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion type Assertion NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_head.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion description "[The ERCC2 genotype appears as an important predictive factor of the survival of patients treated with oxaliplatin in first-line therapy for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion evidence source_evidence_literature NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion SIO_000772 18085999 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion wasDerivedFrom befree-20150227 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion wasGeneratedBy ECO_0000203 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.